Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians
Abstract
Beta-adrenoblockers (ВАВ) are widely used in coronary heart disease (CHD) management. The choice of specific ВАВ and their place in optimal schemes for CHD treatment are discussed.
About the Authors
I. A. Libov
S.P. Botkin Moscow City Clinical Hospital
Russian Federation
Russian Federation
Yu. N. Moiseeva
Russian Medical Academy of Post-Diploma Education
Russian Federation
Moscow.
Russian Federation
Moscow.
A. R. Gaynullina
S.P. Botkin Moscow City Clinical Hospital
Russian Federation
Russian Federation
References
1. Hedblad В, Wikstrand Г, Janzon L, et al. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the beta-blocker cholesterol-lowering asymptomatis plaque study. Circulation 2001; 103: 1721-6.
2. Wiklund О, Hulthe J, Wikstrand J, et al. Effect of controlled release/extended release metoprolol оп carotid intima-media thickness in patients with hypercholesterolemia. А 3-year randomized study. Stroke 2002; 33: 572- 7.
3. Беленков Ю.Н., Мареев В.Ю. Как мы диагностируем и лечим сердечную недостаточность в реальной клинической практике в начале XXI века? Результаты исследования IMPROVEMENТ HF. Cons med 2001; 3(2): 65-72.
4. Kjekshus Г, Apetrei Е, Barrios V, et al. Rosuvastatin in Older Patients with Systolic Heart Failure. N Engl J Med 2007; 357: 2248-61.
5. GISSI-HF investigators. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): а randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 1231-9.
6. Poole-Wtlson РА, Swedberg К, Cleland JGF, et al. Comparison of carvedilol and metoprolol оп clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European trial. Lancet 2003; 362: 7-13.
7. Metoprolol CR/XL Randomized Intervention Study in Heart Failure. Hjalmarson А, Goldstein S, Fagerberg В, et al. Effects of controlled-release metorpolol оп total mortality, hospitalizations, and well-being in patients with heart failure. JАМА 2000; 283: 1295-302.
8. Kuehlkamp V, Schirdewan А, Stangl К, et al. Use of metoprolol CR to maintain sinus rhythm after conversion from persistent atrial fibrillation. Arandomized douЫe-blind placebo-controlled study. Circulation 1998; 98(Suppl 1): 1-633.
9. Olsson G, Rehnkvist N. Reduction in nonfatal reinfarctions in patients with а history of hypertension bу chronic postinfarction treatment with metoprolol. Acta Med Scand 1986; 220: 33-8.
10. Navaпo-Lopez F, Cosin J, Marrugat JБ, et al. Comparison of the effects of amiodarone versus metoprolol оn the frequency of ventricular arrhythmias and оn mortality after acute myocardial infarction. Аm J Cardiol 1993; 72: 1243-8.
Review
For citations:
Libov I.A., Moiseeva Yu.N., Gaynullina A.R. Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians. Cardiovascular Therapy and Prevention. 2009;8(2):68-71. (In Russ.)
Views:
385
Email this article 
